Uncategorized

Read the Drug Patent Clock Before the Market Does: A step-by-step technical guide to forecasting pharmaceutical drug patent expiry for IP teams, R&D strategists, and institutional investors

The drug patent clock is ticking—and most IP teams are forecasting with the wrong instrument.
In pharma, timing isn’t just strategy—it’s value. A few months can decide whether a blockbuster stays protected, whether generics enter cleanly, or whether li…

Read the Drug Patent Clock Before the Market Does: A step-by-step technical guide to forecasting pharmaceutical drug patent expiry for IP teams, R&D strategists, and institutional investors Read Post »

General Biotechnology

Drug Market Entry Intelligence: The Definitive Guide for Pharma Strategists, IP Teams, and Institutional Investors

Pharma strategy is often built on what’s known—but market entry is won on what’s predictable.
In today’s environment—where patent cliffs, generics, biosimilars, and shifting payer dynamics collide—teams can’t afford to rely on intuition or static sprea…

Drug Market Entry Intelligence: The Definitive Guide for Pharma Strategists, IP Teams, and Institutional Investors Read Post »

Biotechblog
Scroll to Top